The history of controlled clinical trials in China. Part 1: from the advent of clinical trials through the conduct of single-centre or small-sample RCTs

Bothwell LE Greene JA Podolsky SH Jones DS. Assessing the gold standard – lessons from the history of RCTs. N Engl J Med 2016; 374: 2175–2181.

Marks HM. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990, 1997. Cambridge: Cambridge University Press.

Cook DJ Guyatt GH Laupacis A Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992; 102: 305S–11S.

Daly J. Evidence-Based Medicine and the Search for a Science of Clinical Care. Oakland: University of California Press, 2005.

Bothwell LE Kuo WH Jones DS Podolsky SH. Social and scientific history of randomized controlled trials. In: Piantadosi S Meinert C , eds. Principles and Practice of Clinical Trials. Cham: Springer, 2020: 3–19.

Chalmers I Dukan E Podolsky S Davey Smith G. The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. J R Soc Med 2012; 105: 221–227.

Li B Yan Y Lv M Zhao G Li Z Feng S. Clinical epidemiology in China series. Paper 1: evidence-based medicine in China: an oral history study. J Clin Epidemiol 2021; 140: 165–171.

Li Y Sun X Wang L. Evidence-based medicine in China. Value Health 2008; 11: S156–S158.

Tang J Zhan S Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999; 319: 160–161.

Tian G Zhao C Zhang X Mu W Jiang Y Wei X. Evidence-based traditional Chinese medicine research: two decades of development, its impact, and breakthrough. J Evidence-Based Med 2021; 14: 65–74.

Senior K. Unique, multilingual resource on testing health-care treatments. Bull World Health Org 2009; 87: 412–413.

Gluud C Wang J. History of evidence-based medicine. In: Wang J Gluud C , eds. Evidence-Based Medicine and Clinical Practice. Beijing: Beijing Science Publisher, 2002:2–4.

Blake HA. Colonial reports – miscellaneous. No. 25. Hong Kong. Bubonic plague. Memorandum on the treatment of patients in their own homes and in local hospitals, 1904.

Lei SH. Neither Donkey nor Horse. Chicago: University of Chicago Press, 2014.

Xie Z Li N. Methodological analysis of clinical articles on therapy evaluation published in Chinese Journal of Integrated Traditional & Western Medicine (in Chinese) 1982–1994. Chin J Integr Trad Western Med 1995; 1: 301–306.

Ding M Wei M He C. Clinical trials and clinical trial unit. Chin J Clin Rehabil 2003; 7: 355–358. [丁明甫,卫茂玲,何成奇(2003). 临床试验与临床试验中心.中国临床康复 7(3): 355–358.]

History of Clinical Trials in China. World Latest Medicine Information 2002; 3: 184. [中国临床实验历史 (2002). 世界最新医学信息文摘 3: 184.]

Liu J. Clinical trials and clinical trial unit. Chin J Evidence-Based Med 2001; 1: 202–204. [刘建平(2001). 临床试验与临床试验中心(CTU). 中国循证医学 1(4): 202–204.]

Liu J. Clinical trials and clinical trial unit. Chin J Integr Trad Western Med 2002; 22: 307–308. [刘建平. 临床试验与临床试验中心(2002). 中国中西医结合杂志 22(4): 307–308.]

Ding D Wang X Zhao G. Professor Zhiyi Xu. Shanghai J Prevent Med 2021; 33: 185. [丁玎,汪萱怡,赵根明(2021). 徐志一教授. 上海预防医学 33(2): 185.]

Su D. Clinical trial design. Natl Med J China 1962; 48: 404–406. [苏德隆. 临床实验设计. 中华医学杂志 1962; 48: 404–406.]

Zhou X Huangfu M Wei M Zhou X Yu J . Clinical observation of furapromidium in the treatment of acute schistosomiasis in children. Natl Med J China 1965; 51: 433–436. [周学章,皇甫铭,魏曼华,等 (1965). 呋喃丙胺治疗儿童急性血吸虫病的临床观察. 中华医学杂志 51(7): 433–436.]

Zhou X Huangfu M Zhou X Wei M Chen S Fan Y , et al. A comparative observation on the treatment of acute schistosomiasis with furapromidium combined with adrenocortical hormones and antimony compounds (abstract). Chin J Int Med 1965; 13: 209. [周学章,皇甫铭,周晓兰,等(1965). 呋喃丙胺与肾上腺皮质激素合并锑剂治疗急性血吸虫病的比较观察（摘要）.中华内科杂志 13(3): 209.]

Yu X Chen Y Podolsky S. History of clinical trials for the treatment of tuberculosis in China. JLL Bulletin: commentaries on the history of treatment evaluation. 2025. See www.jameslindlibrary.org/articles/history-of-clinical-trials-for-the-treatment-of-tuberculosis-in-china/ (last checked 16 May 2025).

Wang S Chu Y Zhang Z , Jiang Y and Yang D. Comparison of the efficacy of different medication regimens for the initial treatment of pulmonary tuberculosis. Chin J Antitubercul 1963; 4: 227–233.[汪士,諸云程,張振朝,等 (1963). 肺結核病初次治疗不同用药方法的疗效比較.中国防痨杂志 4: 227–233.]

Tian L Zhang L Wang N , Zhang H, Cao Y, AL, et al. A retrospective and prospective review of the development of medical research institutions in China over the 60 years since the establishment of the nation. J Med Res 2010; 39: 122–125. [田玲,张黎黎,汪楠,等 (2010). 建国60年我国医学科研机构发展回顾与展望. 医学研究杂志 2010; 39(2): 122–125.]

Yin Y. A retrospective on the academic journal industry in the 60 years of new China. J Sichuan Univ Sci Eng (Soc Sci Ed) 2012; 27: 32–39. [尹玉吉 (2012). 新中国60年学术期刊事业回眸. 四川理工学院学报(社会科学版) 27(4): 32–39.]

Luo D. The flourishing development of clinical epidemiology in China. Natl Med J China 1991; 71: 114. [罗德诚 (1991). 我国临床流行病学的蓬勃发展. 中华医学杂志 71(2): 114.]

Wang S Ji B Ai G Zhang C. Clinical research methods (part 1). Clin Med China 1987; 3: 193–196. [王树岐,纪宝华,艾刚阳,等 (1987). 临床研究方法(一). 临床医学杂志 3(4): 193–196.]

Chen K Qian Z Zhang W Guan W, Hao X, Chen Xet al. The therapeutic effect of purified coronary heart II tablets on 112 cases of angina pectoris by double blind method. Chin J Cardiol 1982; 10: 85–89. [陈可冀,钱振淮,张问渠,等(1982). 精制冠心片双盲法治疗冠心病心绞痛112例疗效分析. 中华心血管病杂志 10(2): 85–89.]

Lin G. Overview of the development of clinical epidemiology in China. Chin J Neurol 1998; 78: 876–877. [林果为(1998). 我国临床流行病学发展简况. 中华神经科杂志 78(11): 876–877.]

Zhou H. How to evaluate drug clinical trial reports. Chin J Clin Pharmacol 1985; 1: 264–267. [周宏灏 (1985). 如何评价药物临床试验报告. 中国临床药理学杂志 1(4): 264–267.]

Hu M. Clinical randomized controlled trial. Chin J Health Stat 1986; 3: 18. [胡孟璇(1986). 临床随机对照试验. 中国卫生统计 3: 18.]

Luo H Shu L Fang M Fang Y, Zhou D, Jia Yet al. Analysis of the therapeutic efficacy of double-blind controlled electroacupuncture and amitriptyline in the treatment of depression. Chin J Neurol 1985; 18: 273. [罗和春,舒良,方明昭,等 (1985). 双盲对照电针与阿咪替林治疗抑郁症疗效分析. 中华神经精神科杂志 18(5): 273.]

Wu D Liu X. David Sackett: a pioneer of evidence-based medicine. Med J Peking Union Medical College Hosp 2020; 11: 449–452. [吴东,刘晓清 (2020). David Sackett:循证医学之父. 协和医学杂志 11(4): 449–452.

Wang W Liu L Tao S Gong L and Wu N , et al. Quality of clinical trials of Chinese herbal drugs – a review of 314 published papers. Chin J Integr Trad Western Med 1994; 14: 50–52 + 6. [俞国培,高思维,李怡,等 (1994). 中药临床治疗试验质量的调查——314篇文献评阅结果. 中国中西医结合杂志 14(1): 50–2 + 6.]

Wang Q Zhang B. Research design and statistical methods in Chinese medical journals. JAMA 1998; 280: 283–285.

Su D. Collected papers of Professor Delong Su. Tianjin: Tianjin Science and Technology Press, 1995:122. [苏德隆 (1995). 苏德隆教授论文选集. 天津科学技术出版社 122.]